Avicanna Announces Results of Annual General and Special Meeting

TORONTO, Oct. 20, 2020 /CNW/ – Avicanna Inc. (“Avicanna” or the “Company“) (TSX: AVCN) (OTCQX: AVCNF) (FSE: 0NN), a biopharmaceutical company focused on the development, manufacturing and commercialization of cannabinoid-based products, is pleased to announce that all of management’s nominees listed in the Company’s management information circular dated September 22, 2020 were elected as directors of the Company at Avicanna’s annualContinue reading “Avicanna Announces Results of Annual General and Special Meeting”

The Valens Company Announces Results of Annual General and Special Meeting of Shareholders

KELOWNA, BC, June 12, 2020 /CNW/ –Valens GroWorks Corp.(TSX: VLNS) (OTCQX: VLNCF) (“Valens” or “The Valens Company“), a global leader in the end-to-end development and manufacturing of innovative, cannabinoid-based products, is pleased to announce the voting results from The Valens Company’s Annual General and Special Meeting of Shareholders (the “Meeting“), held by way of live audio webcast on June 12, 2020. TheContinue reading “The Valens Company Announces Results of Annual General and Special Meeting of Shareholders”